Real-world BRCA1/2 and Homologous Recombination Deficiency Testing Dynamics and Time to Treatment Discontinuation on PARP Inhibitor First-Line Maintenance among Patients with Epithelial Ovarian Cancer
GYNECOLOGIC ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined